Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of dexamethasone and neomycin is a medication used primarily for ophthalmic (eye) conditions. It combines a corticosteroid (dexamethasone) with an antibiotic (neomycin) to treat inflammatory eye conditions where bacterial infection is present or at risk of developing. ## Composition and Formulations This medication is available in several forms: - Ophthalmic suspension (eye drops) - Ophthalmic ointment - Topical preparations for skin conditions The combination works through dual mechanisms: - Dexamethasone: A corticosteroid that reduces inflammation by suppressing the immune system and reducing chemicals that cause pain, redness, and swelling[1][3] - Neomycin: An antibiotic that kills bacteria by preventing them from making essential proteins needed for survival[1][3] ## Uses The dexamethasone + neomycin combination is primarily used for: - Treatment of bacterial eye infections[1][2] - Prevention of bacterial eye infections[1] - Reduction of inflammation, redness, swelling, and itching in the eye[2][3] - Treatment of inflammatory ocular conditions where bacterial infection exists or is at risk[4][6] - Treatment of bacterial skin infections (in topical formulations)[5] ## Administration For ophthalmic suspension (eye drops): - Typically instilled 1-2 drops into the affected eye(s) every 4-6 hours[6][8] - In severe cases, may be used hourly during the day and every 2 hours at night initially, then tapered[6][8] - Should not be used for longer than 10 days unless directed by a doctor[7] For ophthalmic ointment: - Apply a small ribbon (approximately 0.5 inch) to the conjunctival sac of the affected eye(s) every 4-6 hours[8] - May be used as an adjunct to the suspension[8] ## Contraindications The medication should not be used in: - Viral eye infections (including herpes simplex keratitis)[4] - Fungal eye infections[4] - Mycobacterial eye infections[4] - Individuals with known hypersensitivity to any ingredients[4] ## Side Effects Common side effects may include: - Temporary burning, itching, or redness at the application site[5][7] - Blurred vision (temporary)[7] More serious side effects that should be reported to healthcare providers include: - Signs of allergic reaction - Worsening or persistent eye pain - Changes in vision - New or worsening eye symptoms[3][7] ## Precautions - Contact lenses should not be worn while using this medication[7] - Pregnancy category C (not known whether it will harm an unborn baby)[6] - Effects on breastfeeding are not well established[6] - Should not be used for longer than prescribed periods to avoid antibiotic resistance or steroid-related complications[7] ## Brand Names Common brand names for this combination include: - Maxitrol - Dexasporin - Neodecadron - AK-Trol - NeoPolyDex (when combined with polymyxin B)[2][3][4] This medication is available by prescription only and should be used under the supervision of a healthcare provider.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dexamethasone + neomycin.